/
AXIM
$0.00-$0.00 (-20.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.03
6% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-0.43
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $195.6K | $799.5K | $0 | $60.5K | $8.9K | $39.5K | $70.5K | $0 |
| Cost of revenue | $8.5K | $575.7K | $16.0K | $2.1M | $426.1K | $427.0K | $439.7K | $427.4K |
| Gross profit | $187.1K | $223.8K | −$16.0K | $60.5K | −$417.3K | $39.5K | −$369.3K | −$427.4K |
| Gross margin | 95.6% | 28.0% | — | 100.0% | -4701.4% | 100.0% | -524.1% | — |
| R&D | $2.1M | $2.5M | $426.7K | $284.9K | $153.7K | $125.5K | $39.8K | $180.5K |
| Operating income | −$5.0M | −$6.5M | −$4.9M | −$8.0M | −$4.7M | −$2.8M | −$1.8M | −$1.3M |
| EBITDA | −$5.2M | −$2.7M | −$4.9M | −$13.2M | −$3.9M | −$6.4M | −$2.4M | −$892.3K |
| Net income | −$6.8M | −$6.8M | −$6.7M | −$16.5M | −$6.0M | −$8.1M | −$3.5M | −$1.0M |
| Net margin | -3453.0% | -847.0% | — | -27320.8% | -67120.7% | -20395.0% | -4985.2% | — |
| EPS (diluted) | -0.12 | -0.11 | -0.06 | -0.13 | -0.04 | -0.04 | -0.01 | -0.00 |
Annual figures · source: Financial Modeling Prep
Peer comparison
AXIM BIOTECHNOLOGIES INC
AXIM BIOTECHNOLOGIES INC
Held by traders on TradeandTell
No one on the platform currently holds AXIM.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in AXIM as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded AXIM yet.
